QuarterWatch analyzes MedWatch Reports

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.

To read this article, please click here.

Posted in

More RSI News

Norman Shippee joins RSI

February 28, 2017
RSI logo in white

RSI is pleased to announce that Norman Shippee recently joined the team as a Climate and Applications Specialist. Dr. Shippee earned his PhD at the…

Read News Item

Emma Hartnett receives Chauncey Starr Distinguished Young Risk Analyst Award

December 15, 2016
RSI logo in white

The Society for Risk Analysis (SRA) Council has awarded Dr. Hartnett the 2016 Chauncey Starr Distinguished Young Risk Analyst Award. The Chauncey Starr Distinguished Young…

Read News Item

Dr. Donald R. Mattison co-authors: Adult Utilization of Psychiatric Drugs

December 12, 2016
RSI logo in white

Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult…

Read News Item

RSI launches game-changing climate app

June 30, 2016
RSI logo in white

RSI launched the Climate Change Hazards Information Portal (CCHIP).

Read News Item